The SALOME study: Recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency

Substance Abuse: Treatment, Prevention, and Policy

Volumn 10, Issue 1, 2015, Pages

  Oviedo Joekes, Eugenia ^a,b   Marchand, Kirsten ^a,b   Lock, Kurt ^a   MacDonald, Scott ^c   Guh, Daphne ^a   Schechter, Martin T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Providence Health Care   (Canada)

Author keywords

Injectable diacetylmorphine; Injectable hydromorphone; Opioid dependency; Randomized clinical trial; Recruitment

Indexed keywords

DIAMORPHINE; HYDROMORPHONE; NARCOTIC ANALGESIC AGENT;

CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; OPIOID-RELATED DISORDERS; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TIME FACTOR;

ANALGESICS, OPIOID; DOUBLE-BLIND METHOD; FEMALE; HEROIN; HUMANS; HYDROMORPHONE; MALE; OPIOID-RELATED DISORDERS; PATIENT SELECTION; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 84928726553     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/1747-597X-10-3     Document Type: Article

References (23)

1. De Jong CA, Roozen HG, van Rossum LG, Krabbe PF, Kerkhof AJ. High abstinence rates in heroin addicts by a new comprehensive treatment approach. Am J Addict. 2007;16:124-30.
2. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209.
3. Van den Brink W, Haasen C. Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry. 2006;51:635-46.
4. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev. 2011;8:CD003410.
5. Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Nosyk B, Krausz M, et al. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: A pilot study. J Subst Abuse Treat. 2010;38:408-11.
6. Gates S, Brocklehurst P, Campbell M, Elbourne D. Recruitment to multicentre trials. BJOG: An International Journal of Obstetrics & Gynaecology. 2004;111:3-5.
7. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7:9.
8. Treweek S, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, Johansen M, et al. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev. 2010;4:Mr000013.
9. Sully BG, Julious SA, Nicholl J. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies. Trials. 2013;14:166.
10. Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, et al. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess. 2007;11:ii. ix-105.
11. Humphreys K, Maisel NC, Blodgett JC, Finney JW. Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders. J Stud Alcohol Drugs. 2013;74:889-93.
12. Mullins CD, Vandigo J, Zheng Z, Wicks P. Patient-Centeredness in the Design of Clinical Trials. 2014;17:471-5.
13. Points to Consider about Recruitment and Retention While Preparing a Clinical Research Study. [http://www.nimh.nih.gov/funding/grant-writingand-application-process/recruitment-points-to-consider-6-1-05_34848.pdf]
14. Thomson CL, Morley KC, Teesson M, Sannibale C, Haber PS. Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug Alcohol Rev. 2008;27:115-22.
15. Ashery RS, McAuliffe WE. Implementation issues and techniques in randomized trials of outpatient psychosocial treatments for drug abusers: recruitment of subjects. Am J Drug Alcohol Abuse. 1992;18:305-29.
16. Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, et al. Heroin-assisted treatment in the Netherlands: History, findings, and international context. Eur Neuropsychopharmacol. 2010;20 Suppl 2:S105-58.
17. March JC, Oviedo-Joekes E, Romero M, Gomez M, Rodriguez S, Leon MI, et al. [The experimental drug prescription program in Andalusia [PEPSA]: procedure for recruiting participants]. Gac Sanit. 2004;18:245-7.
18. Watson JM, Torgerson DJ. Increasing recruitment to randomised trials: a review of randomised controlled trials. BMC Med Res Methodol. 2006;6:34.
19. Demaret I, Litran G, Magoga C, Deblire C, Dupont A, De Roubaix J, et al. Why do heroin users refuse to participate in a heroin-assisted treatment trial? Heroin Addiction and Related Clinical Problems. 2014;xxx:5-12.
20. March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F. Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat. 2006;31:203-11.
21. Chettiar J, Lock K, Oviedo-Joekes E, Sievewright K, Schechter MT. The recruitment of participants to the Canadian heroin trial: Free heroin is not enough. In: 19th International Harm Reduction Conference, Barcelona, Spain. 2008 Poster presentation.
22. Bond Sutton L, Erlen JA, Glad JM, Siminoff LA. Recruiting vulnerable populations for research: revisiting the ethical issues. J Prof Nurs. 2003;19:106-12.
23. Barratt MJ, Norman JS, Fry CL. Positive and negative aspects of participation in illicit drug research: implications for recruitment and ethical conduct. Int J Drug Policy. 2007;18:235-8.